{"database": "lobbying", "table": "lobbying_activities", "rows": [[2388409, "c9eb9138-d99b-4ab2-8296-e856b32a2ff8", "Q4", "AMERICAN CLINICAL LABORATORY ASSN", 1923, "AMERICAN CLINICAL LABORATORY ASSN", 2019, "fourth_quarter", "DIS", "commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises; H.R. 269 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019, S. 1379 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,White House Office", null, 324826, 0, 0, "2020-01-17T12:27:03.727000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2388409"], "units": {}, "query_ms": 10.416083037853241, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}